 | • レポートコード：MRC23Q35990 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のアイサプリメント市場について調査・分析し、世界のアイサプリメント市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ルテイン、ブルーベリー、グレープシード）、用途別セグメント分析（一般人、近視、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、FANCL、PipingRock、YARRAVIBE、Neptune Pharma As、DHC、Ocuvite、Mcepharma、KEMIN、Swisse、BLACKMORES、Biosyntrx、Nordic Naturals、Bristol-Myers Squibb Company、Healths Harmony USA Supplements、NUSAPURE、Vitabiotics、Bausch & Lombなどが含まれています。世界のアイサプリメント市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、アイサプリメント市場規模を推定する際に考慮しました。本レポートは、アイサプリメントの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、アイサプリメントに関するビジネス上の意思決定に役立てることを目的としています。 ・アイサプリメント市場の概要 - アイサプリメントのタイプ別セグメント - 世界のアイサプリメント市場規模：タイプ別分析（ルテイン、ブルーベリー、グレープシード） - アイサプリメントの用途別セグメント - 世界のアイサプリメント市場規模：用途別分析（一般人、近視、その他） - 世界のアイサプリメント市場規模予測（2018年-2029年） ・アイサプリメント市場の成長トレンド - アイサプリメントの地域別市場規模（2018年-2029年） - アイサプリメント市場ダイナミクス - アイサプリメントの業界動向 - アイサプリメント市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ルテイン、ブルーベリー、グレープシード - 世界のアイサプリメントのタイプ別市場規模（2018年-2023年） - 世界のアイサプリメントのタイプ別市場規模（2024年-2029年） ・用途別セグメント：一般人、近視、その他 - 世界のアイサプリメントの用途別市場規模（2018年-2023年） - 世界のアイサプリメントの用途別市場規模（2024年-2029年） ・アイサプリメントの地域別市場規模 - 北米のアイサプリメント市場規模（2018年-2029年） - アメリカのアイサプリメント市場規模（2018年-2029年） - ヨーロッパのアイサプリメント市場規模（2018年-2029年） - アジア太平洋のアイサプリメント市場規模（2018年-2029年） - 中国のアイサプリメント市場規模（2018年-2029年） - 日本のアイサプリメント市場規模（2018年-2029年） - 韓国のアイサプリメント市場規模（2018年-2029年） - インドのアイサプリメント市場規模（2018年-2029年） - オーストラリアのアイサプリメント市場規模（2018年-2029年） - 中南米のアイサプリメント市場規模（2018年-2029年） - 中東・アフリカのアイサプリメント市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 FANCL、PipingRock、YARRAVIBE、Neptune Pharma As、DHC、Ocuvite、Mcepharma、KEMIN、Swisse、BLACKMORES、Biosyntrx、Nordic Naturals、Bristol-Myers Squibb Company、Healths Harmony USA Supplements、NUSAPURE、Vitabiotics、Bausch & Lomb ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Eye Supplements market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Eye Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Eye Supplements is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Eye Supplements in Ordinary People is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Eye Supplements include FANCL, PipingRock, YARRAVIBE, Neptune Pharma As, DHC, Ocuvite, Mcepharma, KEMIN and Swisse, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eye Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Supplements.
The Eye Supplements market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Eye Supplements market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
FANCL
PipingRock
YARRAVIBE
Neptune Pharma As
DHC
Ocuvite
Mcepharma
KEMIN
Swisse
BLACKMORES
Biosyntrx
Nordic Naturals
Bristol-Myers Squibb Company
Healths Harmony USA Supplements
NUSAPURE
Vitabiotics
Bausch & Lomb
Segment by Type
Lutein
Blueberry
Grape Seeds
Segment by Application
Ordinary People
Myopia People
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eye Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eye Supplements Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Lutein
1.2.3 Blueberry
1.2.4 Grape Seeds
1.3 Market by Application
1.3.1 Global Eye Supplements Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Ordinary People
1.3.3 Myopia People
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eye Supplements Market Perspective (2018-2029)
2.2 Eye Supplements Growth Trends by Region
2.2.1 Global Eye Supplements Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Eye Supplements Historic Market Size by Region (2018-2023)
2.2.3 Eye Supplements Forecasted Market Size by Region (2024-2029)
2.3 Eye Supplements Market Dynamics
2.3.1 Eye Supplements Industry Trends
2.3.2 Eye Supplements Market Drivers
2.3.3 Eye Supplements Market Challenges
2.3.4 Eye Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eye Supplements Players by Revenue
3.1.1 Global Top Eye Supplements Players by Revenue (2018-2023)
3.1.2 Global Eye Supplements Revenue Market Share by Players (2018-2023)
3.2 Global Eye Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eye Supplements Revenue
3.4 Global Eye Supplements Market Concentration Ratio
3.4.1 Global Eye Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eye Supplements Revenue in 2022
3.5 Eye Supplements Key Players Head office and Area Served
3.6 Key Players Eye Supplements Product Solution and Service
3.7 Date of Enter into Eye Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eye Supplements Breakdown Data by Type
4.1 Global Eye Supplements Historic Market Size by Type (2018-2023)
4.2 Global Eye Supplements Forecasted Market Size by Type (2024-2029)
5 Eye Supplements Breakdown Data by Application
5.1 Global Eye Supplements Historic Market Size by Application (2018-2023)
5.2 Global Eye Supplements Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Eye Supplements Market Size (2018-2029)
6.2 North America Eye Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Eye Supplements Market Size by Country (2018-2023)
6.4 North America Eye Supplements Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Eye Supplements Market Size (2018-2029)
7.2 Europe Eye Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Eye Supplements Market Size by Country (2018-2023)
7.4 Europe Eye Supplements Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eye Supplements Market Size (2018-2029)
8.2 Asia-Pacific Eye Supplements Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Eye Supplements Market Size by Region (2018-2023)
8.4 Asia-Pacific Eye Supplements Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Eye Supplements Market Size (2018-2029)
9.2 Latin America Eye Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Eye Supplements Market Size by Country (2018-2023)
9.4 Latin America Eye Supplements Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eye Supplements Market Size (2018-2029)
10.2 Middle East & Africa Eye Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Eye Supplements Market Size by Country (2018-2023)
10.4 Middle East & Africa Eye Supplements Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FANCL
11.1.1 FANCL Company Detail
11.1.2 FANCL Business Overview
11.1.3 FANCL Eye Supplements Introduction
11.1.4 FANCL Revenue in Eye Supplements Business (2018-2023)
11.1.5 FANCL Recent Development
11.2 PipingRock
11.2.1 PipingRock Company Detail
11.2.2 PipingRock Business Overview
11.2.3 PipingRock Eye Supplements Introduction
11.2.4 PipingRock Revenue in Eye Supplements Business (2018-2023)
11.2.5 PipingRock Recent Development
11.3 YARRAVIBE
11.3.1 YARRAVIBE Company Detail
11.3.2 YARRAVIBE Business Overview
11.3.3 YARRAVIBE Eye Supplements Introduction
11.3.4 YARRAVIBE Revenue in Eye Supplements Business (2018-2023)
11.3.5 YARRAVIBE Recent Development
11.4 Neptune Pharma As
11.4.1 Neptune Pharma As Company Detail
11.4.2 Neptune Pharma As Business Overview
11.4.3 Neptune Pharma As Eye Supplements Introduction
11.4.4 Neptune Pharma As Revenue in Eye Supplements Business (2018-2023)
11.4.5 Neptune Pharma As Recent Development
11.5 DHC
11.5.1 DHC Company Detail
11.5.2 DHC Business Overview
11.5.3 DHC Eye Supplements Introduction
11.5.4 DHC Revenue in Eye Supplements Business (2018-2023)
11.5.5 DHC Recent Development
11.6 Ocuvite
11.6.1 Ocuvite Company Detail
11.6.2 Ocuvite Business Overview
11.6.3 Ocuvite Eye Supplements Introduction
11.6.4 Ocuvite Revenue in Eye Supplements Business (2018-2023)
11.6.5 Ocuvite Recent Development
11.7 Mcepharma
11.7.1 Mcepharma Company Detail
11.7.2 Mcepharma Business Overview
11.7.3 Mcepharma Eye Supplements Introduction
11.7.4 Mcepharma Revenue in Eye Supplements Business (2018-2023)
11.7.5 Mcepharma Recent Development
11.8 KEMIN
11.8.1 KEMIN Company Detail
11.8.2 KEMIN Business Overview
11.8.3 KEMIN Eye Supplements Introduction
11.8.4 KEMIN Revenue in Eye Supplements Business (2018-2023)
11.8.5 KEMIN Recent Development
11.9 Swisse
11.9.1 Swisse Company Detail
11.9.2 Swisse Business Overview
11.9.3 Swisse Eye Supplements Introduction
11.9.4 Swisse Revenue in Eye Supplements Business (2018-2023)
11.9.5 Swisse Recent Development
11.10 BLACKMORES
11.10.1 BLACKMORES Company Detail
11.10.2 BLACKMORES Business Overview
11.10.3 BLACKMORES Eye Supplements Introduction
11.10.4 BLACKMORES Revenue in Eye Supplements Business (2018-2023)
11.10.5 BLACKMORES Recent Development
11.11 Biosyntrx
11.11.1 Biosyntrx Company Detail
11.11.2 Biosyntrx Business Overview
11.11.3 Biosyntrx Eye Supplements Introduction
11.11.4 Biosyntrx Revenue in Eye Supplements Business (2018-2023)
11.11.5 Biosyntrx Recent Development
11.12 Nordic Naturals
11.12.1 Nordic Naturals Company Detail
11.12.2 Nordic Naturals Business Overview
11.12.3 Nordic Naturals Eye Supplements Introduction
11.12.4 Nordic Naturals Revenue in Eye Supplements Business (2018-2023)
11.12.5 Nordic Naturals Recent Development
11.13 Bristol-Myers Squibb Company
11.13.1 Bristol-Myers Squibb Company Company Detail
11.13.2 Bristol-Myers Squibb Company Business Overview
11.13.3 Bristol-Myers Squibb Company Eye Supplements Introduction
11.13.4 Bristol-Myers Squibb Company Revenue in Eye Supplements Business (2018-2023)
11.13.5 Bristol-Myers Squibb Company Recent Development
11.14 Healths Harmony USA Supplements
11.14.1 Healths Harmony USA Supplements Company Detail
11.14.2 Healths Harmony USA Supplements Business Overview
11.14.3 Healths Harmony USA Supplements Eye Supplements Introduction
11.14.4 Healths Harmony USA Supplements Revenue in Eye Supplements Business (2018-2023)
11.14.5 Healths Harmony USA Supplements Recent Development
11.15 NUSAPURE
11.15.1 NUSAPURE Company Detail
11.15.2 NUSAPURE Business Overview
11.15.3 NUSAPURE Eye Supplements Introduction
11.15.4 NUSAPURE Revenue in Eye Supplements Business (2018-2023)
11.15.5 NUSAPURE Recent Development
11.16 Vitabiotics
11.16.1 Vitabiotics Company Detail
11.16.2 Vitabiotics Business Overview
11.16.3 Vitabiotics Eye Supplements Introduction
11.16.4 Vitabiotics Revenue in Eye Supplements Business (2018-2023)
11.16.5 Vitabiotics Recent Development
11.17 Bausch & Lomb
11.17.1 Bausch & Lomb Company Detail
11.17.2 Bausch & Lomb Business Overview
11.17.3 Bausch & Lomb Eye Supplements Introduction
11.17.4 Bausch & Lomb Revenue in Eye Supplements Business (2018-2023)
11.17.5 Bausch & Lomb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details